Catherine E. Luke

Southern Association for Vascular Surgery William J. von Leibig Award. Inflammation and intimal hyperplasia associated with experimental pulmonary embolism.

Experimental pulmonary embolism: effects of the thrombus and attenuation of pulmonary artery injury by low-molecular-weight heparin.

Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.

Postthrombotic vein wall remodeling: preliminary observations.

Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.

Toll-like receptor 9 signaling is critical for early experimental deep vein thrombosis resolution.

The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling.

Matrix metalloproteinase-9 deletion is associated with decreased mid-term vein wall fibrosis in experimental stasis DVT.

Divergent effects of Tlr9 deletion in experimental late venous thrombosis resolution and vein wall injury.

Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice.

Alterations in macrophage phenotypes in experimental venous thrombosis.

In Vivo Role of Neutrophil Extracellular Traps in Antiphospholipid Antibody-Mediated Venous Thrombosis.

Gram-Negative Pneumonia Alters Large-Vein Cell-Adhesion Molecule Profile and Potentiates Experimental Stasis Venous Thrombosis.

Pre-Clinical Model to Study Recurrent Venous Thrombosis in the Inferior Vena Cava.

Ly6CLo Monocyte/Macrophages are Essential for Thrombus Resolution in a Murine Model of Venous Thrombosis.

Modulation of interleukin-6 and its effect on late vein wall injury in a stasis mouse model of deep vein thrombosis.

Experimental venous thrombus resolution is driven by IL-6 mediated monocyte actions.

Smart thrombosis inhibitors without bleeding side effects via charge tunable ligand design.